Influence of the extent of cervical lymph node dissection and lymph nodes metastases on prognosis in a cohort of dogs with oral malignant melanoma treated by surgical resection and adjuvant anti-CSPG4 electrovaccination: a retrospective study on 77 cases
- PMID: 40786979
- PMCID: PMC12333538
- DOI: 10.3389/fvets.2025.1616419
Influence of the extent of cervical lymph node dissection and lymph nodes metastases on prognosis in a cohort of dogs with oral malignant melanoma treated by surgical resection and adjuvant anti-CSPG4 electrovaccination: a retrospective study on 77 cases
Abstract
The most appropriate approach to regional/sentinel lymph nodes (LN) for staging canine oral malignant melanoma (OMM) is still controversial. This study aims to retrospectively evaluate the prognostic impact of neck dissection modality and LN metastasis in a homogeneous cohort of dogs treated by surgery and adjuvant anti-CSPG4 electrovaccination. Seventy-seven dogs were enrolled and divided into two groups based on the presence (Group A, 24 dogs) or absence (Group B, 53 dogs) of histologically confirmed LN metastasis at the time of surgery. The overall LN metastatic rate was 31%; metastasis was found mostly in the mandibular lymph center (83%). Median survival time (MST) and disease-free interval (DFI) in Group A were 406 and 134 days, respectively. Although shorter, these values were not significantly different from MST and DFI in Group B (534 and 219 days, respectively; p = 0.16 and p = 0.11). Stratifying the cases based on the type of lymphadenectomy performed, no statistical differences were observed between Groups 1 (ipsilateral lymphadenectomy) and 2 (bilateral lymphadenectomy) regarding both MST and DFI. Similarly, no significant differences in MST and DFI were observed among subgroups based on ipsilateral (Group 4) and bilateral (Group 6) removal versus ipsilateral (Group 3) and bilateral (Group 5) non-removal of even the medial retropharyngeal LN. No association was found between LN metastasis and recurrence or distant metastasis. Finally, no association was found between lymphadenectomy pattern and progressive disease. The results recorded in this study, i.e., that ipsilateral mandibular lymphadenectomy may be a reasonable surgical option in OMM, apply for this cohort of dogs only, and the translation of this principle to canine OMMs differently treated needs further investigations. Additionally, further efforts should be addressed to studies on sentinel LN identification for canine OMM staging.
Keywords: CSPG4; dog; lymph node; lymph node dissection; oral malignant melanoma.
Copyright © 2025 Giacobino, Olimpo, Ferraris, Martinelli, Maniscalco, Camerino, Riccardo, Cavallo, Tarone, Cino, Dentini, Iussich, Lardone, Manassero, Maria, Buracco and Morello.
Conflict of interest statement
SI was employed by Veterinary Analysis Laboratory srl. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
-
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.Cochrane Database Syst Rev. 2015 May 16;2015(5):CD010307. doi: 10.1002/14651858.CD010307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25978975 Free PMC article.
-
Lymphadenectomy for the management of endometrial cancer.Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD007585. doi: 10.1002/14651858.CD007585.pub4. Cochrane Database Syst Rev. 2017. PMID: 28968482 Free PMC article.
-
Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer.Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD015786. doi: 10.1002/14651858.CD015786.pub2. Cochrane Database Syst Rev. 2025. PMID: 40492478 Review.
-
Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment.Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD006205. doi: 10.1002/14651858.CD006205.pub5. Cochrane Database Syst Rev. 2023. PMID: 37650478 Free PMC article.
References
-
- Bergman PJ, Selmic LE, Kent MS. Melanoma In: Vail DM, Thamm DH, Liptak JM, editors. The Withrow and Mac Ewen's small animal clinical oncology. 6th ed. St. Louis: Elsevier; (2020). 367–81.
-
- Camerino M, Giacobino D, Manassero L, Iussich S, Riccardo F, Cavallo F, et al. Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: a retrospective study on 68 cases (2010–2020). Vet Comp Oncol. (2022) 20:189–97. doi: 10.1111/vco.12761, PMID: - DOI - PMC - PubMed
-
- Giacobino D, Camerino M, Riccardo F, Cavallo F, Tarone L, Martano M, et al. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: a retrospective study on 155 cases. Vet Comp Oncol. (2021) 19:651–60. doi: 10.1111/vco.12690, PMID: - DOI - PMC - PubMed
-
- Liptak JM. Oral tumors In: Vail DM, Thamm DH, Liptak JM, editors. The Withrow and Mac Ewen's small animal clinical oncology. 6th ed. St. Louis, MO: Elsevier; (2020). 432–48.
LinkOut - more resources
Full Text Sources